scispace - formally typeset
S

Sture Rognstad

Researcher at University of Oslo

Publications -  17
Citations -  538

Sture Rognstad is an academic researcher from University of Oslo. The author has contributed to research in topics: Academic detailing & Medical prescription. The author has an hindex of 9, co-authored 17 publications receiving 509 citations.

Papers
More filters
Journal ArticleDOI

The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: A modified Delphi study

TL;DR: The NORGEP criteria may serve as rules of thumb for general practitioners related to their prescribing practice for elderly patients, and as a tool for evaluating the quality of GPs’ prescribing in settings where access to clinical information for individual patients is limited, e.g. in prescription databases and quality improvement interventions.
Journal ArticleDOI

A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450]

TL;DR: The main outcome of this trial is the change in proportions of inappropriate prescriptions (QIs) for elderly patients ≥ 70 years following intervention, compared to baseline levels.
Journal ArticleDOI

Prescription peer academic detailing to reduce inappropriate prescribing for older patients: a cluster randomised controlled trial

TL;DR: In this paper, the effects of a multifaceted educational intervention on GPs' PIPs for older patients were investigated in a cluster randomised, educational intervention study in Norwegian general practice.
Journal ArticleDOI

Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice – The Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155]

TL;DR: The hypothesis is that an educational intervention program will be effective in improving prescription patterns by reducing the total number of antibiotic prescriptions, as well as reducing the amount of broad-spectrum antibiotics, with special emphasis on macrolides.